tiprankstipranks
BeiGene gets FDA orphan designation in Waldenstrom macroglobulinemia treatment
PremiumThe FlyBeiGene gets FDA orphan designation in Waldenstrom macroglobulinemia treatment
1M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
1M ago
BeiGene announces global licensing agreement for MAT2A inhibitor
Premium
The Fly
BeiGene announces global licensing agreement for MAT2A inhibitor
1M ago
BeiGene settles litigation against generic filer of Brukinsa
PremiumThe FlyBeiGene settles litigation against generic filer of Brukinsa
2M ago
BeiGene announces proposed name change to ‘BeOne Medicines’
Premium
The Fly
BeiGene announces proposed name change to ‘BeOne Medicines’
2M ago
BeiGene Reports Strong Revenue Growth in Q3 2024
Premium
Company Announcements
BeiGene Reports Strong Revenue Growth in Q3 2024
2M ago
BeiGene to share new Brukinsa data at ASH Annual Meeting
PremiumThe FlyBeiGene to share new Brukinsa data at ASH Annual Meeting
2M ago
Indaptus Therapeutics announces clinical supply agreement with BeiGene
Premium
The Fly
Indaptus Therapeutics announces clinical supply agreement with BeiGene
3M ago
BeiGene price target raised to $235 from $200 at JPMorgan
Premium
The Fly
BeiGene price target raised to $235 from $200 at JPMorgan
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100